恆指收復逾300點失地僅微跌 平安好醫生及阿里健康升幅擴至9%-10%齊破頂
新冠肺炎疫情自今年初暴發以來,並擴散至全球大流行,令在線醫療及醫藥服務需求激增,而隨著內地復工復產加速推進,檢測需求亦將進一步快速增加。網上診症股近日逆市反覆探頂,尤其是本月上旬推出英文版全球抗疫平台為全球用戶提供每天24小時新冠肺炎在線諮詢的平安好醫生(01833.HK)連續第三天反覆創紀錄高,今早股價低開報104.8元拒絕再下,掉頭再破頂,午後高見117.5元,現造116.8元,升幅擴至9.1%,成交653萬股。
開通全國核酸檢測預約服務及最快一天可獲取電子報告的阿里健康(00241.HK)扭轉早段窄幅整固(曾低見16.68元),半日高收回升9%破頂後,下午升幅擴大,最高18.98元,現造18.8元,揚10%,成交增至5,315萬股,涉資9.54億元。
天貓聯合阿里健康及合作夥伴昨日(21日)推出核酸檢測預約服務,首批上線京滬穗、杭州、成都、南京、深圳、西安、溫州及濟南等10個城市,最快一天可獲取電子報告。合作夥伴有美年大健康天貓旗艦店、迪安健檢天貓旗艦店等。阿里方面透露,隨著合作的擴大,包括重慶、天津、武漢、寧波、青島及廈門在內28個城市,都會在本周內陸續上線。支付寶APP近期也將上線同一服務。
恆指午後收復今早曾續跌逾300點大部分失地,報23,787,僅吐6點,成交額563億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.